Venture Map · Round
ELEM Biotech — Other · €1.2M
Announced 2021-12-17 · Barcelona · Healthtech / In-silico clinical trials
ELEM Biotech, a spin-off of the Barcelona Supercomputing Center, raised about €1.2M through Capital Cell crowdfunding at a €7.5M pre-money valuation to bring V.HEART to market. V.HEART runs cardiac clinical trials on virtual human populations. Namarel Ventures and Roger Assaker are among the family-office and angel backers.
RoundOther
Amount€1.2M
LeadNot disclosed
Date2021-12-17
CityBarcelona
SectorHealthtech / In-silico clinical trials
The company
Investors 2
N
Namarel Ventures
R
Roger Assaker